Aulisa Multiple Patient Digital Vital Sign Monitoring System
K-Number: K202497 · 2020-10-30
Decision Date2020-10-30
Product CodeMSX
Advisory CommitteeCV
DecisionSubstantially Equivalent
Device Summary
Aulisa Multiple Patient Digital Vital Sign Monitoring System is a medical device manufactured by Taiwan Aulisa Medical Devices Technologies, Inc.. It received FDA 510(k) clearance on 2020-10-30 under approval number K202497. The device is classified under product code MSX. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.
Frequently Asked Questions
What is the Aulisa Multiple Patient Digital Vital Sign Monitoring System?
Aulisa Multiple Patient Digital Vital Sign Monitoring System is a medical device that received FDA 510(k) clearance on 2020-10-30. It is manufactured by Taiwan Aulisa Medical Devices Technologies, Inc.. The 510(k) number is K202497.
When was Aulisa Multiple Patient Digital Vital Sign Monitoring System approved by the FDA?
Aulisa Multiple Patient Digital Vital Sign Monitoring System received FDA 510(k) clearance on 2020-10-30, under approval number K202497.
What company makes Aulisa Multiple Patient Digital Vital Sign Monitoring System?
Aulisa Multiple Patient Digital Vital Sign Monitoring System is manufactured by Taiwan Aulisa Medical Devices Technologies, Inc..
What is the FDA product code for Aulisa Multiple Patient Digital Vital Sign Monitoring System?
The FDA product code for Aulisa Multiple Patient Digital Vital Sign Monitoring System is MSX.
Related Clinical Trials
NCT07614139
Continuous Glucose Monitoring Alerts, Accuracy, and Patient Outcomes in Adults With Inherited Metabolic Disorders
COMPLETED
NCT06998134
Toward Ubiquitous Lower Limb Exoskeleton Use in Children and Young Adults
RECRUITING
NCT06011187
Assisted Fluid Management (AFM) System and Postoperative Outcome After High-risk Abdominal Surgery
COMPLETED
NCT07301385
Evaluation of Head-Mounted Spatial Computing and Three-Dimensional (3D) Visualization in Ocular Microsurgery: A Safety and Workflow Study
ACTIVE_NOT_RECRUITING
NCT07599982
Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes
RECRUITING
NCT07092761
Evaluation of the Accuracy and Safety of A Novel Real-Time Continuous Glucose Monitoring System
RECRUITING
Related PubMed Literature
PMID: 42174947
Aligning AI-Native 6G Healthcare Systems with EU Ethical and Legal Frameworks.
Studies in health technology and informatics (2026)
PMID: 41982627
Cybersecurity breaches in medical devices: analyzing FDA safety communications in response to patient security concerns.
Frontiers in digital health (2026)
PMID: 41970523
Large language models in healthcare quality management: a European perspective on process automation and compliance.
Frontiers in digital health (2026)
PMID: 41966529
Comparison of the AccuPower HIV-1 Quant Kit and Aptima HIV-1 Quant Dx Assay for quantification of HIV-1 plasma viral load.
Diagnostic microbiology and infectious disease (2026)
Other Devices by Taiwan Aulisa Medical Devices Technologies, Inc.
K162580Guardian Angel GA1000 Digital Vital Sign Monitoring System
K191207Guardian Angel Rx GA2001 Digital Vital Sign Monitoring System
K182822Guardian Angel Rx GA 1001 Digital Vital Sign Monitoring System
K183067Guardian Angel Rx GA2000 Digital Vital Sign Monitoring System
K203208Guardian Angel Rx GA2000 Series Digital Vital Sign Monitoring System
K240220Aulisa Temperature Module (TM0002)
Related Devices (Code: MSX)
K153156eCareManager 4.0.1Visicu, Inc.
K160862AirStrip RPMAirstrip Technologies, Inc.
K161164CareEvent inclusive of the CareEvent Mobile Application accessoryPhilips Medical Systems
K171322eCareManager 4.1Visicu, Inc.
K162607BeneVision Central Monitoring SystemShenzhen Mindray Bio-Medical Electronics Co., Ltd.
K180430Digistat Smart CentralAscom Ums Srl Unipersonale
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.